Harnessing Bacterial Agents to Modulate the Tumor Microenvironment and Enhance Cancer Immunotherapy

被引:3
|
作者
Thomas, Christina James [1 ]
Delgado, Kaylee [1 ]
Sawant, Kamlesh [1 ]
Roy, Jacob [1 ]
Gupta, Udit [1 ]
Song, Carly Shaw [1 ]
Poojary, Rayansh [1 ]
de Figueiredo, Paul [2 ]
Song, Jianxun [1 ]
机构
[1] Texas A&M Univ, Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, MREB 2,Room 3344,8447 John Sharp Pkwy, Bryan, TX 77807 USA
[2] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA
关键词
cancer immunotherapy; tumor microenvironment; engineered bacteria; immunosuppression; immune checkpoint inhibitors; bacterial therapeutics; antitumor immunity; ATTENUATED SALMONELLA-TYPHIMURIUM; METASTATIC BREAST-CANCER; ACTIVATION GENE-3 LAG-3; T-CELL DIFFERENTIATION; CLOSTRIDIUM-NOVYI-NT; SUPPRESSOR-CELLS; BACTERIOLYTIC THERAPY; DENDRITIC CELLS; IN-VITRO; HPV E7;
D O I
10.3390/cancers16223810
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer immunotherapy has revolutionized cancer treatment by leveraging the immune system to attack tumors. However, its effectiveness is often hindered by the immunosuppressive tumor microenvironment (TME), where a complex interplay of tumor, stromal, and immune cells undermines antitumor responses and allows tumors to evade immune detection. This review explores innovative strategies to modify the TME and enhance immunotherapy outcomes, focusing on the therapeutic potential of engineered bacteria. These bacteria exploit the unique characteristics of the TME, such as abnormal vasculature and immune suppression, to selectively accumulate in tumors. Genetically modified bacteria can deliver therapeutic agents, including immune checkpoint inhibitors and cytokines, directly to tumor sites. This review highlights how bacterial therapeutics can target critical immune cells within the TME, such as myeloid-derived suppressor cells and tumor-associated macrophages, thereby promoting antitumor immunity. The combination of bacterial therapies with immune checkpoint inhibitors or adoptive cell transfer presents a promising strategy to counteract immune suppression. Continued research in this area could position bacterial agents as a powerful new modality to reshape the TME and enhance the efficacy of cancer immunotherapy, particularly for tumors resistant to conventional treatments.
引用
收藏
页数:24
相关论文
共 50 条
  • [21] The Role of Tumor Microenvironment in Cancer Immunotherapy
    Chen Xue-Man
    Song Er-Wei
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2017, 44 (08) : 641 - 648
  • [22] Tumor microenvironment and immunotherapy of oral cancer
    Liu, Chang
    Wang, Min
    Zhang, Haiyang
    Li, Chunyan
    Zhang, Tianshou
    Liu, Hong
    Zhu, Song
    Chen, Jie
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)
  • [23] Reprogramming tumor microenvironment in cancer immunotherapy
    Kalinski, Pawel
    Muthuswamy, Ravikumar
    Obermajer, Natasa
    Zeh, Herbert
    Zureikat, Amer
    Edwards, Robert
    Bartlett, David
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [24] Targeting DKK3 to remodel tumor immune microenvironment and enhance cancer immunotherapy
    Kai Shi
    Yan Zhao
    Hao Ye
    Xiaoming Zhu
    Zhenghai Chen
    BMC Cancer, 25 (1)
  • [25] Remodeling the inflammatory breast cancer tumor microenvironment to enhance immunotherapy: Novel therapeutic development
    Wang, Xiaoping
    Semba, Takashi
    Manyam, Ganiraju C.
    Wang, Jing
    Shao, Shan
    Bertucci, Francois
    Finetti, Pascal
    Krishnamurthy, Savitri
    Phi, Lan ThiHanh
    Pearson, Troy
    Burks, Jared K.
    Cohen, Evan N.
    Reuben, James M.
    Yang, Fei
    Min, Hu
    Navin, Nicholas
    Iwase, Toshiaki
    Shen, Yichao
    Zhang, Xiang
    Tripathy, Debu
    Ueno, Naoto T.
    CANCER RESEARCH, 2022, 82 (04)
  • [26] OVERCOMING THE SUPPRESSIVE TUMOR MICROENVIRONMENT WITH A LIVE BACTERIAL IMMUNOTHERAPY
    Scott, Andrew
    Besneux, Matthieu
    Oke, Oluwatobiloba
    Chol, Mary
    Prevosto, Claudia
    Glanville, Nicholas
    Deban, Livija
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A858 - A858
  • [27] Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy
    Musetti, Sara
    Huang, Leaf
    ACS NANO, 2018, 12 (12) : 11740 - 11755
  • [28] Editorial: Harnessing tumor microenvironment for gynecologic cancer therapy
    Zhou, Linying
    Yi, Ming
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [29] Targeting Myeloid-derived Suppressive Cells in the Tumor Microenvironment to Enhance the Efficacy of Cancer Immunotherapy
    Huo, Shuping
    Liu, Liang
    Li, Qiaomin
    Wang, Jing
    DISCOVERY MEDICINE, 2020, 30 (161) : 119 - 128
  • [30] Pyroptosis Remodeling Tumor Microenvironment to Enhance Pancreatic Cancer Immunotherapy Driven by Membrane Anchoring Photosensitizer
    Wang, Meng
    Wu, Min
    Liu, Xingang
    Shao, Shiyi
    Huang, Junmin
    Liu, Bin
    Liang, Tingbo
    ADVANCED SCIENCE, 2022, 9 (29)